Liver-targeting medications (such as resmetirom, fibroblast growth factor 21 analogs and lanifibranor), aiming at liver inflammation and collagen deposition, are expected to become crucial in individuals with more advanced liver disease [138]
This metabolic adaptation is a survival mechanism that served our ancestors well but now works against weight loss goals
J Clin Res Pediatr Endocrinol
Both medicines can cause gastrointestinal side effects
Peptides studied in metabolic medicine include GLP-1 analogs, MOTS-C, and others involved in mitochondrial function, appetite regulation, and immune signaling.
Welcome to Navitus Welcome to Navitus Redefining Pharmacy Benefits with People in Mind With innovative, people-centered solutions, Navitus is transforming pharmacy benefit management to deliver cost-effective medication plans for plan sponsors and health plans